Oncotarget
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases.The term was introduced in the inaugural Editorial,Introducing Oncotarget.
As of January 1, 2022,Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Learn about ourFREE
Impact Journals, LLC is the publisher of Oncotarget:www.impactjournals.com.
Impact Journals is a member of theWellcome Trust List of Compliant Publishers.
Impact Journals is a member of theSociety for Scholarly Publishing.
On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control.This malicious action will be reported to the FBI.
10.18632/ONCOTARGET.23208 |
10.18632/ONCOTARGET.6429 |
10.18632/ONCOTARGET.9859 |
10.18632/ONCOTARGET.13553 |
10.18632/ONCOTARGET.14401 |
10.18632/ONCOTARGET.15422 |
10.18632/ONCOTARGET.16407 |
10.18632/ONCOTARGET.19087 |
Most popular Oncotarget DOIs, measured by the number of times each DOI was successfully resolved.
On August 25, 2022, the Office of Science and Technology Policy announced a new government policy legislating the immediate public release of all United States-funded research publications by 2025.Learn more here andhere.
On May 23, 2023, the Council of the European Union adopted conclusions on high-quality, transparent, open, trustworthy, and equitable scholarly publishing. The Council calls for immediate and unrestricted open access to publishing research involving public funds.Learn more.
ED-A is expressed both in primary tumors and metastases in the MMTV-PyMT model of mammary carcinoma. SeeFemel et al.
BRAF vs RAS oncogenes: Are mutations of the same pathway equal? Differential signalling and therapeutic implications |
https://doi.org/10.18632/oncotarget.2555 Eftychia Oikonomou,Evangelos Koustas,Maria Goulielmaki, and Alexander Pintzas |
11752-11777 |
Abstract | PDF | HTML | How to cite |
Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation |
https://doi.org/10.18632/oncotarget.2634 Ulrike Keitel,Andreas Scheel,Jürgen Thomale,Rovena Halpape,Silke Kaulfuß,Christina Scheel, and Matthias Dobbelstein |
11778-11791 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
WW domain-containing oxidoreductase in neuronal injury and neurological diseases |
https://doi.org/10.18632/oncotarget.2961 Hsin-Tzu Chang,Chan-Chuan Liu,Shur-Tzu Chen,Ye Vone Yap,Nan-Shang Chang, and Chun-I Sze |
11792-11799 |
Abstract | PDF | HTML | How to cite |
ROS production, intracellular HSP70 levels and their relationship in human neutrophils: effects of age |
https://doi.org/10.18632/oncotarget.2856 Elena I. Kovalenko,Anna A. Boyko,Victor F. Semenkov,Gennady V. Lutsenko,Maria V. Grechikhina,Leonid M. Kanevskiy,Tatyana L. Azhikina,William G. Telford, and Alexander M. Sapozhnikov |
11800-11812 |
Abstract | PDF | HTML | How to cite |
A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly |
https://doi.org/10.18632/oncotarget.2952 Tathiana Azevedo de Andrade,Adriane Feijo Evangelista,Antonio Hugo Froes Campos,Wagner Augusto Poles,Natalia Morais Borges,Claudia Malheiros Coutinho Camillo,Fernando Augusto Soares,Jose Vassallo,Roberto Pinto Paes,Maria Claudia Zerbini,Cristovam Scapulatempo,Antonio Correa Alves,Ken H. Young, and Gisele Wally Braga Colleoni |
11813-11826 |
Abstract | PDF | HTML | How to cite |
Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and for growth inhibition of breast cancer cells and cancer stem-like cells. |
https://doi.org/10.18632/oncotarget.2582 Itay Pickholtz,Shira Saadyan,Gilmor I. Keshet,Victor S. Wang,Rachel Cohen,Peter Bouwman,Jos Jonkers,Stephen W. Byers,Moshe Z. Papa, and Ronit I. Yarden |
11827-11846 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells |
https://doi.org/10.18632/oncotarget.2663 Hisato Kawakami,Isamu Okamoto,Kimio Yonesaka,Kunio Okamoto,Kiyoko Shibata,Yume Shinkai,Haruka Sakamoto,Michiko Kitano,Takao Tamura,Kazuto Nishio, and Kazuhiko Nakagawa |
11847-11856 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Phospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stability |
https://doi.org/10.18632/oncotarget.2613 Mi Hee Park,Kang-Yell Choi,Yunjin Jung, and Do Sik Min |
11857-11872 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A |
https://doi.org/10.18632/oncotarget.2662 Hongxia Chen,Lingmin Li,Shaojun Wang,Yupeng Lei,Qi Ge,Nonghua Lv,Xiaodong Zhou, and Changyan Chen |
11873-11885 |
Abstract | PDF | HTML | How to cite |
Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells |
https://doi.org/10.18632/oncotarget.2620 Yang Yang,Dan Su,Lin Zhao,Dan Zhang,Jiaying Xu,Jianmei Wan,Saijun Fan, and Ming Chen |
11886-11896 |
Abstract | PDF | HTML | How to cite |
Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells |
https://doi.org/10.18632/oncotarget.2472 Giulia Guzzo,Marco Sciacovelli,Paolo Bernardi, and Andrea Rasola |
11897-11908 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells |
https://doi.org/10.18632/oncotarget.2557 Wangbing Chen,Jianjun Lu,Yu Qin,Jingshu Wang,Yun Tian,Dingbo Shi,Shusen Wang,Yao Xiao,Meng Dai,Lu Liu,Guo Wei,Taihua Wu,Bilian Jin,Xiangsheng Xiao,Tie-Bang Kang,Wenlin Huang, and Wuguo Deng |
11909-11923 |
Abstract | PDF | HTML | How to cite |
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas |
https://doi.org/10.18632/oncotarget.2650 Lorena Landuzzi,Marianna L. Ianzano,Giordano Nicoletti,Arianna Palladini,Valentina Grosso,Dario Ranieri,Massimiliano Dall’Ora,Elena Raschi,Roberta Laranga,Marco Gambarotti,Piero Picci,Carla De Giovanni,Patrizia Nanni, and Pier-Luigi Lollini |
11924-11938 |
Abstract | PDF | HTML | How to cite |
Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response |
https://doi.org/10.18632/oncotarget.2654 Nian-Kang Sun,Shang-Lang Huang,Pu-Yuan Chang,Hsing-Pang Lu, and Chuck C.-K. Chao |
11939-11956 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts |
https://doi.org/10.18632/oncotarget.2566 Mylène Honorat,Jérôme Guitton,Charlotte Gauthier,Charlotte Bouard,Florine Lecerf-Schmidt,Basile Peres,Raphaël Terreux,Héloïse Gervot,Catherine Rioufol,Ahcène Boumendjel,Alain Puisieux,Attilio Di Pietro, and Léa Payen |
11957-11970 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2in vitro andin vivo |
https://doi.org/10.18632/oncotarget.2647 Xiao-kun Wang,Kenneth Kin Wah To,Li-yan Huang,Jing-hong Xu,Ke Yang,Fang Wang,Zhen-cong Huang,Sheng Ye, and Li-wu Fu |
11971-11985 |
Abstract | PDF | HTML | How to cite |
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma |
https://doi.org/10.18632/oncotarget.2388 Ye Yang,Wen Zhou,Jiliang Xia,Zhimin Gu,Erik Wendlandt,Xin Zhan,Siegfried Janz,Guido Tricot, and Fenghuang Zhan |
11986-11997 |
Abstract | PDF | HTML | How to cite |
The orthologous Tbx transcription factors Omb and TBX2 induce epithelial cell migration and extrusion in vivo without involvement of matrix metalloproteinases |
https://doi.org/10.18632/oncotarget.2426 Jie Shen,Juan Lu,Liyuan Sui,Dan Wang,Meizhen Yin,Inka Hoffmann,Anne Legler, and Gert O. Pflugfelder |
11998-12015 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Role of p53 in the progression of gastric cancer |
https://doi.org/10.18632/oncotarget.2434 Rita A. Busuttil,Giada V. Zapparoli,Sue Haupt,Christina Fennell,Stephen Q. Wong,Jia-Min B. Pang,Elena A. Takeno,Catherine Mitchell,Natasha Di Costanzo,Stephen Fox,Ygal Haupt,Alexander Dobrovic, and Alex Boussioutas |
12016-12026 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation |
https://doi.org/10.18632/oncotarget.2482 Muly Tham,Kar Wai Tan,Jo Keeble,Xiaojie Wang,Sandra Hubert,Luke Barron,Nguan Soon Tan,Masashi Kato,Armelle Prevost-Blondel,Veronique Angeli, and Jean-Pierre Abastado |
12027-12042 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells |
https://doi.org/10.18632/oncotarget.2658 Martin Puhr,Julia Hoefer,Hannes Neuwirt,Iris E. Eder,Johann Kern,Georg Schäfer,Stephan Geley,Isabel Heidegger,Helmut Klocker, and Zoran Culig |
12043-12056 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.2666 Yanmei Cui,Chuyong Lin,Zhiqiang Wu,Aibin Liu,Xin Zhang,Jinrong Zhu,Geyan Wu,Jueheng Wu,Mengfeng Li,Jun Li, and Libing Song |
12057-12069 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway |
https://doi.org/10.18632/oncotarget.2514 Subash C. Gupta,Ramesh Singh,Radhika Pochampally,Kounosuke Watabe, and Yin-Yuan Mo |
12070-12082 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma |
https://doi.org/10.18632/oncotarget.2499 Jiwei Zhang,Bojian Fei,Qifeng Wang,Mingxu Song,Yuan Yin,Binbin Zhang,Shujuan Ni,Weijie Guo,Zehua Bian,Chao Quan,Zhihui Liu,Yugang Wang,Jian Yu,Xiang Du,Dong Hua, and Zhaohui Huang |
12083-12096 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis |
https://doi.org/10.18632/oncotarget.2503 Sayeda Yasmin-Karim,Michael R. King,Edward M. Messing, and Yi-Fen Lee |
12097-12110 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Cooperative interactions between p53 and NFκB enhance cell plasticity |
https://doi.org/10.18632/oncotarget.2545 Alessandra Bisio,Judit Zámborszky,Sara Zaccara,Mattia Lion,Toma Tebaldi,Vasundhara Sharma,Ivan Raimondi,Federica Alessandrini,Yari Ciribilli, and Alberto Inga |
12111-12125 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling |
https://doi.org/10.18632/oncotarget.2573 Neil Rajan,Richard J.R. Elliott,Alice Smith,Naomi Sinclair,Sally Swift,Christopher J. Lord, and Alan Ashworth |
12126-12140 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b |
https://doi.org/10.18632/oncotarget.2559 Pinchas Tsukerman,Rachel Yamin,Einat Seidel,Saleh Khawaled,Dominik Schmiedel,Tomer Bar-Mag, and Ofer Mandelboim |
12141-12150 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis |
https://doi.org/10.18632/oncotarget.2569 Ritesh K. Srivastava,Samer Zaid Kaylani,Nayf Edrees,Changzhao Li,Sarang S. Talwelkar,Jianmin Xu,Komaraiah Palle,Joseph G. Pressey, and Mohammad Athar |
12151-12165 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Molecular profiling and computational network analysis of TAZ-mediated mammary tumorigenesis identifies actionable therapeutic targets |
https://doi.org/10.18632/oncotarget.2570 Costa Frangou,Ying-Wei Li,He Shen,Nuo Yang,Kayla E. Wilson,Maxime Blijlevens,Jin Guo,Norma J. Nowak, and Jianmin Zhang |
12166-12176 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells |
https://doi.org/10.18632/oncotarget.2601 Hui-Chao Zhou,Jian-Hong Fang,Xu Luo,Lei Zhang,Jine Yang,Chong Zhang, and Shi-Mei Zhuang |
12177-12188 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy |
https://doi.org/10.18632/oncotarget.2608 Wenfeng Fang,Jianwei Zhang,Shaodong Hong,Jianhua Zhan,Nan Chen,Tao Qin,Yanna Tang,Yaxiong Zhang,Shiyang Kang,Ting Zhou,Xuan Wu,Wenhua Liang,Zhihuang Hu,Yuxiang Ma,Yuanyuan Zhao,Ying Tian,Yunpeng Yang,Cong Xue,Yue Yan,Xue Hou,Peiyu Huang,Yan Huang,Hongyun Zhao, and Li Zhang |
12189-12202 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling |
https://doi.org/10.18632/oncotarget.2622 Lauren A. Baldwin,John T. Hoff,Jason Lefringhouse,Michael Zhang,Changhe Jia,Zeyi Liu,Sonia Erfani,Hongyan Jin,Mei Xu,Qing-Bai She,John R. van Nagell,Chi Wang,Li Chen,Rina Plattner,David M. Kaetzel,Jia Luo,Michael Lu,Dava West,Chunming Liu,Fred R. Ueland,Ronny Drapkin,Binhua P. Zhou, and Xiuwei H. Yang |
12203-12217 |
Abstract | PDF | HTML | How to cite |
A recessive variant of XRCC4 predisposes to non- BRCA1/2 breast cancer in chinese women and impairs the DNA damage response via dysregulated nuclear localization |
https://doi.org/10.18632/oncotarget.2623 Min He,Xin Hu,Li Chen,A-Yong Cao,Ke-Da Yu,Ting-Yan Shi,Xia-Ying Kuang,Wen-Biao Shi,Hong Ling,Shan Li,Feng Qiao,Ling Yao,Qingyi Wei,Gen-Hong Di, and Zhi-Ming Shao |
12218-12232 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Prognostic significance of catalase expression and its regulatory effects on hepatitis B virus X protein (HBx) in HBV-related advanced hepatocellular carcinomas |
https://doi.org/10.18632/oncotarget.2625 Mi-Young Cho,Jae Youn Cheong,Wonchung Lim,Sujin Jo,Youngsoo Lee,Hee-Jung Wang,Kyou-Hoon Han, and Hyeseong Cho |
12233-12246 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma |
https://doi.org/10.18632/oncotarget.2627 Wan-Ling Ho,Chih-Hsing Chou,Yung-Ming Jeng,Meng-Yao Lu,Yung-Li Yang,Shiann-Tarng Jou,Dong-Tsamn Lin,Hsiu-Hao Chang,Kai-Hsin Lin,Wen-Ming Hsu, and Min-Chuan Huang |
12247-12259 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.2630 So-Young Yeo,Sang Yun Ha,Eun Ji Yu,Keun-Woo Lee,Jeong Hoon Kim, and Seok-Hyung Kim |
12260-12272 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway |
https://doi.org/10.18632/oncotarget.2631 Tsai-Hsien Hung,Sheng-Chi Hsu,Ching-Yi Cheng,Kong-Bung Choo,Ching-Ping Tseng,Tse-Ching Chen,Ying-Wei Lan,Tsung-Teng Huang,Hsin-Chih Lai,Chuan-Mu Chen, and Kowit-Yu Chong |
12273-12290 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer |
https://doi.org/10.18632/oncotarget.2577 Yue Zhang,Fu-Jun Zhao,Li-Lan Chen,Luo-Qiao Wang,Kenneth P. Nephew,Ying-Li Wu, and Shu Zhang |
12291-12303 |
Abstract | PDF | HTML | How to cite |
Targeting cytosolic phospholipase A2 α in colorectal cancer cells inhibits constitutively activated protein kinase B (AKT) and cell proliferation |
https://doi.org/10.18632/oncotarget.2639 Zhong Zheng,Xiangyi He,Chanlu Xie,Sheng Hua,Jianfang Li,Tingfeng Wang,Mu Yao,Soma Vignarajan,Ying Teng,Leila Hejazi,Bingya Liu, and Qihan Dong |
12304-12316 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.2640 Yukiyo Tada,Shoichiro Kokabu,Goro Sugiyama,Chihiro Nakatomi,Kazuhiro Aoki,Hidefumi Fukushima,Kenji Osawa,Yasutaka Sugamori,Keiichi Ohya,Masato Okamoto,Tomoyuki Fujikawa,Akiko Itai,Kou Matsuo,Seiji Watanabe, and Eijiro Jimi |
12317-12330 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells |
https://doi.org/10.18632/oncotarget.2589 Bo-Ra Lee,Sun-Young Chang,Eun-Hye Hong,Bo-Eun Kwon,Hong Min Kim,Yeon-Jeong Kim,Jongkook Lee,Hyun-Jong Cho,Jae-Hee Cheon, and Hyun-Jeong Ko |
12331-12345 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models |
https://doi.org/10.18632/oncotarget.2641 Yukihiko Hiroshima,Yong Zhang,Takashi Murakami,Ali Maawy,Shinji Miwa,Mako Yamamoto,Shuya Yano,Sho Sato,Masashi Momiyama,Ryutaro Mori,Ryusei Matsuyama,Takashi Chishima,Kuniya Tanaka,Yasushi Ichikawa,Michael Bouvet,Itaru Endo,Ming Zhao, and Robert M. Hoffman |
12346-12357 |
Abstract | PDF | HTML | How to cite |
Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells |
https://doi.org/10.18632/oncotarget.2590 Sajjeev Jaganathan,Ehsan Malek,Subrahmanya Vallabhapurapu,Sivakumar Vallabhapurapu, and James J. Driscoll |
12358-12370 |
Abstract | PDF | HTML | How to cite |
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.2642 Houda Alachkar,Martin B.G. Mutonga,Klaus H. Metzeler,Noreen Fulton,Gregory Malnassy,Tobias Herold,Karsten Spiekermann,Stefan K. Bohlander,Wolfgang Hiddemann,Yo Matsuo,Wendy Stock, and Yusuke Nakamura |
12371-12382 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model |
https://doi.org/10.18632/oncotarget.2592 Zhuo Zhang,Hiroe Shiratsuchi,Jules Lin,Guoan Chen,Rishindra M. Reddy,Ebrahim Azizi,Shamileh Fouladdel,Andrew C. Chang,Lin Lin,Hui Jiang,Meghna Waghray,Gary Luker,Diane M. Simeone,Max S. Wicha,David G. Beer,Nithya Ramnath, and Sunitha Nagrath |
12383-12397 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues |
https://doi.org/10.18632/oncotarget.2643 Rongwei Sun,Xudong Wang,Huijun Zhu,Haijun Mei,Wei Wang,Shu Zhang, and Jianfei Huang |
12398-12409 |
Abstract | PDF | HTML | How to cite |
Tamoxifen represses alcohol-induced transcription of RNA polymerase III-dependent genes in breast cancer cells |
https://doi.org/10.18632/oncotarget.2678 Qian Zhong,Ganggang Shi,Qingsong Zhang,Lei Lu,Daniel Levy, and Shuping Zhong |
12410-12417 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer |
https://doi.org/10.18632/oncotarget.2628 Julia Femel,Elisabeth J.M. Huijbers,Falk Saupe,Jessica Cedervall,Lei Zhang,Pernilla Roswall,Erik Larsson,Helena Olofsson,Kristian Pietras,Anna Dimberg,Lars Hellman, and Anna-Karin Olsson |
12418-12427 |
Abstract | PDF | HTML | How to cite |
TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR |
https://doi.org/10.18632/oncotarget.2660 Kun Wang,Tiantian Liu,Nan Ge,Li Liu,Xiaotian Yuan,Jikai Liu,Feng Kong,Chang Wang,Hongbo Ren,Keqiang Yan,Sanyuan Hu,Zhonghua Xu,Magnus Björkholm,Yidong Fan,Shengtian Zhao,Cheng Liu, and Dawei Xu |
12428-12439 |
Abstract | PDF | HTML | Supplementary Information | How to cite |
Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: Analysis of 1806 cases |
https://doi.org/10.18632/oncotarget.2574 Zoran Gatalica,Sherri Z. Millis,Semir Vranic,Ryan Bender,Gargi D. Basu,Andreas Voss, and Daniel D. Von Hoff |
12440-12447 |
Abstract | PDF | HTML | How to cite |
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone |
https://doi.org/10.18632/oncotarget.2558 Ugo De Giorgi,Paola Caroli,Salvatore L. Burgio,Cecilia Menna,Vincenza Conteduca,Emanuela Bianchi,Francesca Fabbri,Elisa Carretta,Dino Amadori,Giovanni Paganelli, and Federica Matteucci |
12448-12458 |
Abstract | PDF | HTML | How to cite |
Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy |
https://doi.org/10.18632/oncotarget.2560 Qingguo Li,Changhua Zhuo,Guoxiang Cai,Dawei Li,Lei Liang, and Sanjun Cai |
12459-12471 |
Abstract | PDF | HTML | How to cite |